Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
about
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeAssembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion exportMultiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesisA36-dependent actin filament nucleation promotes release of vaccinia virusAssembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacksAFM review study on pox viruses and living cells.Repulsion of superinfecting virions: a mechanism for rapid virus spread.Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L proteinVaccinia virus intracellular mature virions contain only one lipid membrane.The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.Extracellular vaccinia virus envelope glycoprotein encoded by the A33R geneVaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challengeAssembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium.Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.Role of cell-associated enveloped vaccinia virus in cell-to-cell spreadA mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and releaseFrom actually toxic to highly specific--novel drugs against poxviruses.Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein.Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.Retrograde Transport from Early Endosomes to the trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virus Virions.A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.The cellular antiviral restriction factor tetherin does not inhibit poxviral replicationThe extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells.Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.Vaccinia virus utilizes microtubules for movement to the cell surface.A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus.Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
P2860
Q24535956-4D22756F-66FB-4AF5-B1FB-CC7BC89BB57FQ24647704-E177483C-A1B7-41DE-ACDA-671A6EB47C62Q27315837-BD0545B9-09CB-4EFD-B086-EAD61A04CD89Q27325801-359C7990-4E79-43C7-9F7F-D8712AD480B0Q27335617-0D26D7A7-B34A-4575-BE11-87F293562760Q29039026-6263B35F-BF88-4AC1-A9DE-AEE0B9D9323CQ30537976-D90F4004-ECFC-449B-9805-B63E91D87ABBQ30594313-23A48C74-F4F4-4092-932E-215972C84492Q33302240-DFB2B423-BA86-4442-A13F-31408CD57D10Q33640531-E21B6055-DC9E-41B9-B9B1-512F77B8B877Q33641762-A658D667-1D2E-45FC-A03A-461A9834EDC6Q33782803-2C0C2B65-1134-4540-AC53-5C20036E5D5BQ35241371-1C5546EB-BEC6-4F06-B3E2-DCF749E50074Q35839800-81151A44-57E3-4D87-9E08-3CAEFA9E66D1Q35860922-54D5E25F-3DAF-444C-8195-74E36948493CQ35861514-4A7A09CD-1D03-4AD9-9EB9-2798284A44F7Q36498244-6629546F-3377-4B2E-BEC7-2A4F02693B76Q36619094-3F226CCC-AB82-45A7-B2F8-22CA7B0D8379Q36647697-64BCC1D2-B873-43EB-9E33-2FD9704EA61BQ36652057-C9CE1CA8-100E-4262-B224-30DE1FDDF655Q36687208-4614E938-6395-41BA-9B1E-79BF7E04A815Q36698801-8D177723-97C5-4003-AE03-E069E90A33E7Q36700431-EEED16E8-35CB-415A-A612-73384091E2B8Q36708435-E7A90C94-5996-4412-889F-8E11CAF99EE2Q36797593-FE28FA1D-3184-493E-A6D3-EAB9351CB53BQ36820928-076FCDAB-51D4-4798-8E79-FB2F00527D4AQ37252890-CB8F3C5C-6F52-4EB5-8299-65DE04501D2AQ37507215-4851CBFC-9626-4C1D-BFA7-7A6E8F00EE5BQ38699683-4EE5FF5D-ED61-40FF-BD65-29EC2395EB1BQ39441885-803AB2C6-55DD-4AF1-B9A7-53F486BAA181Q39577986-2C7AF780-CE43-46ED-A974-1706E452902BQ39872072-850E0095-14A4-4B12-A67C-535C87F17D1CQ39996451-6E500DAD-0FDC-4467-8EC7-33AD3FD161ECQ40059268-E4F0F26B-3D0D-4424-BED0-3F73E30D86E0Q40064533-86D71FDE-8BC1-4E38-B553-90AEE9F2ED8CQ40136590-8A86E404-F034-4D7A-ADF5-D31A5569CB7EQ40145028-0FD8E45A-B307-434A-93DF-512B7E09EBAEQ40790144-8C2B5C13-065E-47FA-BC51-4BBD162E202FQ41064981-9B5BAD0E-5125-4F58-999D-61F0D90190F0Q42108903-F9C04EB9-B718-4CF1-8CBD-12F5059C8F11
P2860
Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Mechanism of vaccinia virus re ...... thyl-4-chlorobenzoylhydrazine.
@en
type
label
Mechanism of vaccinia virus re ...... thyl-4-chlorobenzoylhydrazine.
@en
prefLabel
Mechanism of vaccinia virus re ...... thyl-4-chlorobenzoylhydrazine.
@en
P2860
P1433
P1476
Mechanism of vaccinia virus re ...... thyl-4-chlorobenzoylhydrazine.
@en
P2093
Kristenson K
P2860
P304
P407
P577
1979-11-01T00:00:00Z